Prudent Man Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $936K | Sell |
5,045
-93
| -2% | -$17.3K | 0.3% | 80 |
|
|
2025
Q1 | $1.08M | Buy |
5,138
+124
| +2% | +$26K | 0.39% | 56 |
|
|
2024
Q4 | $891K | Sell |
5,014
-826
| -14% | -$147K | 0.32% | 72 |
|
|
2024
Q3 | $1.15M | Buy |
5,840
+2,289
| +64% | +$452K | 0.38% | 63 |
|
|
2024
Q2 | $609K | Buy |
3,551
+149
| +4% | +$25.6K | 0.22% | 106 |
|
|
2024
Q1 | $620K | Sell |
3,402
-201
| -6% | -$36.6K | 0.23% | 105 |
|
|
2023
Q4 | $558K | Sell |
3,603
-220
| -6% | -$34.1K | 0.21% | 108 |
|
|
2023
Q3 | $570K | Buy |
3,823
+23
| +0.6% | +$3.43K | 0.23% | 104 |
|
|
2023
Q2 | $512K | Sell |
3,800
-72
| -2% | -$9.7K | 0.19% | 111 |
|
|
2023
Q1 | $617K | Sell |
3,872
-95
| -2% | -$15.1K | 0.24% | 98 |
|
|
2022
Q4 | $641K | Buy |
3,967
+52
| +1% | +$8.4K | 0.26% | 96 |
|
|
2022
Q3 | $525K | Sell |
3,915
-530
| -12% | -$71.1K | 0.25% | 89 |
|
|
2022
Q2 | $681K | Sell |
4,445
-1,317
| -23% | -$202K | 0.32% | 59 |
|
|
2022
Q1 | $934K | Sell |
5,762
-98
| -2% | -$15.9K | 0.38% | 51 |
|
|
2021
Q4 | $793K | Sell |
5,860
-1,098
| -16% | -$149K | 0.3% | 60 |
|
|
2021
Q3 | $751K | Buy |
6,958
+40
| +0.6% | +$4.32K | 0.28% | 75 |
|
|
2021
Q2 | $779K | Sell |
6,918
-39
| -0.6% | -$4.39K | 0.3% | 66 |
|
|
2021
Q1 | $753K | Sell |
6,957
-510
| -7% | -$55.2K | 0.32% | 67 |
|
|
2020
Q4 | $800K | Buy |
7,467
+651
| +10% | +$69.7K | 0.34% | 58 |
|
|
2020
Q3 | $597K | Buy |
6,816
+4,462
| +190% | +$391K | 0.32% | 69 |
|
|
2020
Q2 | $231K | Buy |
+2,354
| New | +$231K | 0.21% | 128 |
|